A new hybrid system capable of efficient lentiviral vector production and stable gene transfer mediated by a single helper-dependent adenoviral vector

Journal of Virology

Volumn 77, Issue 5, 2003, Pages 2964-2971

  Kubo, Shuji ^a   Mitani, Kohnosuke ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE CASSETTE; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LENTIVIRINAE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADENOVIRUSES, HUMAN; ANIMALS; CELL LINE; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HELA CELLS; HELPER VIRUSES; HUMANS; LENTIVIRUS; LUMINESCENT PROTEINS; TRANSDUCTION, GENETIC; TRANSFECTION; VIRAL PROTEINS;

EID: 0037370612     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.5.2964-2971.2003     Document Type: Article

References (70)

1. Ackland-Berglund, C. E., and D. A. Leib. 1995, Efficacy of tetracycline-controlled gene expression is influenced by cell type, BioTechniques 18:196-200.
2. + cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G. J. Virol. 70:2581-2585.
3. Akli, S., C. Caillaud, E. Vinge, L. D. Stratford-Perricaudet, L. Poenaru, M. Perricaudet, A. Kahn, and M. R. Peschanski. 1993. Transfer of a foreign gene into the brain using adenovirus vectors. Nat. Genet. 3:224-228.
4. Anderson, W. F. 1998. Human gene therapy. Nature 392:25-30.
5. Benihoud, K., P. Yeh, and M. Perricaudet. 1999. Adenovirus vectors for gene delivery. Curr. Opin. Biotechnol. 10:440-447.
6. Bilbao, G., M. Feng, C. Rancourt, W. H. Jackson, Jr., and D. T. Curiel. 1997. Adenoviral/retroviral vector chimeras: a novel strategy to achieve high-efficiency stable transduction in vivo. FASEB J. 11:624-634.
7. Bosch, A., P. B. McCray, Jr., S. M. Chang, T. R. Ulich, W. S. Simonet, D. J. Jolly, and B. L. Davidson. 1996. Proliferation induced by keratinocyte growth factor enhances in vivo retroviral-mediated gene transfer to mouse hepatocytes. J. Clin. Investig. 98:2683-2687.
8. Burcin, M. M., G. Schiedner, S. Kochanek, S. Y. Tsai, and B. W. O'Malley. 1999. Adenovirus-mediated regulable target gene expression in vivo. Proc. Natl. Acad. Sci. USA 96:355-360.
9. Caplen, N. J., J. N. Higginbotham, J. R. Scheel, N. Vahanian, Y. Yoshida, H. Hamada, R. M. Blaese, and W. J. Ramsey. 1999. Adeno-retroviral chimeric viruses as in vivo transducing agents. Gene Ther. 6:454-459.
10. Chung, J. H., M. Whiteley, and G. Felsenfeld. 1993. A 5′ element of the chicken beta-globin domain serves as an insulator in human erythroid cells and protects against position effect in Drosophila. Cell 74:505-514.
11. DuBridge, R. B., P. Tang, H. C. Hsia, P. M. Leong, J. H. Miller, and M. P. Calos. 1987. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol. Cell. Biol. 7:379-387.
12. Duisit, G., A. Salvetti, P. Moullier, and F. L. Cosset. 1999. Functional characterization of adenoviral/retroviral chimeric vectors and their use for efficient screening of retroviral producer cell lines. Hum. Gene Ther. 10:189-200.
13. Dull, T., R. Zufferey, M. Kelly, R. J. Mandel, M. Nguyen, D. Trono, and L. Naldini. 1998. A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72:8463-8471.
14. Farson, D., R. Witt, R. McGuinness, T. Dull, M. Kelly, J. Song, R. Radeke, A. Bukovsky, A. Consiglio, and L. Naldini. 2001. A new-generation stable inducible packaging cell line for lentiviral vectors. Hum. Gene Ther. 12:981-997.
15. Feng, M., W. H. Jackson, Jr., C. K. Goldman, C. Rancourt, M. Wang, S. K. Dusing, G. Siegal, and D. T. Curiel. 1997. Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector. Nat. Biotechnol. 15:866-870.
16. Follenzi, A., L. E. Ailles, S. Bakovic, M. Geuna, and L. Naldini. 2000. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat. Genet. 25:217-222.
17. Gossen, M., and H. Bujard. 1995. Efficacy of tetracycline-controlled gene expression is influenced by cell type. BioTechniques 19:213-216.
18. Gossen, M., S. Freundlieb, G. Bender, G. Müller, W. Hillen, and H. Bujard. 1995. Transcriptional activation by tetracyclines in mammalian cells. Science 268:1766-1769.
19. Graham, F. L., J. Smiley, W. C. Russell, and R. Nairn. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:59-74.
20. Harui, A., S. Suzuki, S. Kochanek, and K. Milani. 1999. Frequency and stability of chromosomal integration of adenovirus vectors. J. Virol. 73:6141-6146.
21. Howe, J. R., B. V. Skryabin, S. M. Belcher, C. A. Zerillo, and C. Schmauss. 1995. The responsiveness of a tetracycline-sensitive expression system differs in different cell lines. J. Biol. Chem. 270:14168-14174.
22. Huard, J., H. Lochmuller, G. Acsadi, A. Jani, B. Massie, and G. Karpati. 1995. The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. Gene Ther. 2:107-115.
23. Inoue, T., H. Yamaza, Y. Sakai, S. Mizuno, M. Ohno, N. Hamasaki, and Y. Fukumaki. 1999. Position-independent human beta-globin gene expression mediated by a recombinant adeno-associated virus vector carrying the chicken beta-globin insulator. Hum. Genet. 44:152-162.
24. Jaffe, H. A., C. Danel, G. Longenecker, M. Metzger, Y. Setoguchi, M. A. Rosenfeld, T. W. Gant, S. S. Thorgeirsson, L. D. Stratford-Perricaudet, M. Perricaudet, A. Pavirani, J. P. Lecocq, and R. G. Crystal. 1992. Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nat. Genet. 1:372-378.
25. Kafri, T., U. Blomer, D. A. Peterson, F. H. Gage, and I. M. Verma. 1997. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat. Genet. 17:314-317.
26. Kafri, T., H. van Praag, L. Ouyang, F. H. Gage, and I. M. Verma. 1999. A packaging cell line for lentivirus vectors. J. Virol. 73:576-584.
27. Kass-Eisler, A., E. Falck-Pedersen, D. H. Elfenbein, M. Alvira, P. M. Buttrick, and L. A. Leinwand. 1994. The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer. Gene Ther. 1:395-402.
28. Kochanek, S. 1999. High-capacity adenoviral vectors for gene transfer and somatic gene therapy. Hum. Gene Ther. 10:2451-2459.
29. Kremer, E. J., and M. Perricaudet. 1995. Adenovirus and adeno-associated virus mediated gene transfer. Br. Med. Bull. 51:31-44.
30. Kubo, S., K. Kiwaki, H. Awata, H. Katoh, Y. Kanegae, I. Saito, T. Yamamoto, J. Miyazaki, I. Matsuda, and F. Endo. 1997. In vivo correction with recombinant adenovirus of 4-hydroxyphenylpyruvic acid dioxygenase deficiencies in strain III mice. Hum. Gene Ther. 8:65-71.
31. Kwok, W. W., F. Schuening, R. B. Stead, and A. D. Miller. 1986. Retroviral transfer of genes into canine hemopoietic progenitor cells in culture: a model for human gene therapy. Proc. Natl. Acad. Sci. USA 83:4552-4555.
32. Lefrancois, L., and D. S. Lyles. 1982. The interaction of antibody with the major surface glycoprotein of vesicular stomatitis virus. I. Analysis of neutralizing epitopes with monoclonal antibodies. Virology 121:157-167.
33. Li, Q., M. A. Kay, M. Finegold, L. D. Stratford-Perricaudet, and S. L. Woo. 1993. Assessment of recombinant adenoviral vectors for hepatic gene therapy. Hum. Gene Ther. 4:403-409.
34. Milani, K., F. L. Graham, C. T. Caskey, and S. Kochanek. 1995. Rescue, propagation, and partial purification of a helper virus-dependent adenovirus vector. Proc. Natl. Acad. Sci. USA 92:3854-3858.
35. Miyoshi, H., U. Blomer, M. Takahashi, F. H. Gage, and I. M. Verma. 1998. Development of a self-inactivating lentivirus vector. J. Virol. 72:8150-8157.
36. Monahan, P. E., and R. J. Samulski. 2000. AAV vectors: is clinical success on the horizon? Gene Ther. 7:24-30.
37. Morral, N., W. O'Neal, K. Rice, M. Leland, J. Kaplan, P. A. Piedra, H. Zhou, R. J. Parks, R. Velji, E. Aguilar-Cordova, S. Wadsworth, F. L. Graham, S. Kochanek, K. D. Carey, and A. L. Beaudet. 1999. Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons. Proc. Natl. Acad. Sci. USA 96:12816-12821.
38. Morsy, M. A., E. L. Alford, A. Bett, F. L. Graham, and C. T. Caskey. 1993. Efficient adenoviral-mediated ornithine transcarbamylase expression in deficient mouse and human hepatocytes. J. Clin. Investig. 92:1580-1586.
39. Naldini, L. 1998. Lentiviruses as gene transfer agents for delivery to nondividing cells. Curr. Opin. Biotechnol. 9:457-463.
40. Naldini, L., U. Blomer, P. Gallay, D. Ory, R. Mulligan, F. H. Gage, I. M. Verma, and D. Trono. 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267.
41. Ng, P., R. J. Parks, and F. L. Graham. 2002. Preparation of helper-dependent adenoviral vectors. Methods Mol. Med. 69:371-388.
42. Oka, K., L. Pastore, I. H. Kim, A. Merched, S. Nomura, H. J. Lee, M. Merched-Sauvage, C. Arden-Riley, B. Lee, M. Finegold, A. Beaudet, and L. Chan. 2001. Long-term stable correction of low-density lipoprotein receptor-deficient mice with a helper-dependent adenoviral vector expressing the very low-density lipoprotein receptor. Circulation 103:1274-1281.
43. Pages, J. C., M. Andreoletti, M. Bennoun, C. Vons, J. Elcheroth, P. Lehn, D. Houssin, J. Chapman, P. Briand, R. Benarous, et al. 1995. Efficient retroviral-mediated gene transfer into primary culture of murine and human hepatocytes: expression of the LDL receptor. Hum. Gene Ther. 6:21-30.
44. Park, F., K. Ohashi, W. Chiu, L. Naldini, and M. A. Kay. 2000. Efficient lentiviral transduction of liver requires cell cycling in vivo. Nat. Genet. 24:49-52.
45. Park, F., K. Ohashi, and M. A. Kay. 2000. Therapeutic levels of human factor VIII and IX using HIV-1-based lentiviral vectors in mouse liver. Blood 96:1173-1176.
46. Parks, R. J., L. Chen, M. Anton, U. Sankar, M. A. Rudnicki, and F. L. Graham. 1996. A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal. Proc. Natl. Acad. Sci. USA 93:13565-13570.
47. Patijn, G. A., A. Lieber, D. B. Schowalter, R. Schwall, and M. A. Kay. 1998. Hepatocyte growth factor induces hepatocyte proliferation in vivo and allows for efficient retroviral-mediated gene transfer in mice. Hepatology 28:707-716.
48. Quantin, B., L. D. Perricaudet, S. Tajbakhsh, and J.-L. Mandel. 1992. Adenovirus as an expression vector in muscle cells in vivo. Proc. Natl. Acad. Sci. USA 89:2581-2584.
49. Reiser, J., G. Harmison, S. Kluepfel-Stahl, R. O. Brady, S. Karlsson, and M. Schubert. 1996. Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles. Proc. Natl. Acad. Sci. USA 93:15266-15271.
50. Rivera, V. M., X. Ye, N. L. Courage, J. Sachar, F. Cerasoli, Jr., J. M. Wilson, and M. Gilman. 1999. Long-term regulated expression of growth hormone in mice after intramuscular gene transfer. Proc. Natl. Acad. Sci. USA 96:8657-8662.
51. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed., p, 16.32-16.36. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
52. Sandig, V., R. Youil, A. J. Bett, L. L. Franlin, M. Oshima, D. Maione, F. Wang, M. L. Metzker, R. Savino, and C. T. Caskey. 2000. Optimization of the helper-dependent adenovirus system for production and potency in vivo. Proc. Natl. Acad. Sci. USA 97:1002-1007.
53. Schiedner, G., N. Morral, R. J. Parks, Y. Wu, S. C. Koopmans, C. Langston, F. L. Graham, A. L. Beaudet, and S. Kochanek. 1998. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nat. Genet. 18:180-183.
54. Schuening, F. G., R. Storb, R. B. Stead, S. Goehle, R. Nash, and A. D. Miller. 1989. Improved retroviral transfer of genes into canine hematopoietic progenitor cells kept in long-term marrow culture. Blood 74:152-155.
55. Seidman, M. A., S. M. Hogan, R. L. Wendland, S. Worgall, R. G. Crystal, and P. L. Leopold. 2001. Variation in adenovirus receptor expression and adenovirus vector-mediated transgene expression at defined stages of the cell cycle. Mol. Ther. 4:13-21.
56. Sena-Esteves, M., Y. Saeki, C. Fraefel, and X. O. Breakefield. 2000. HSV-1 amplicon vectors - simplicity and versatility. Mol. Ther. 2:9-15.
57. Stratford-Perricaudet, L. D., M. Levrero, J.-F. Chasse, M. Perricaudet, and P. Briand. 1990. Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector. Hum. Gene Ther. 1:241-256.
58. Tang, H., K. L. Kuhen, and F. Wong-Staal. 1999. Lentivirus replication and regulation. Annu. Rev. Genet. 33:133-170.
59. Thalmeier, K., P. Meissner, G. Reisbach, M. Falk, A. Brechtel, and P. Dormer. 1994. Establishment of two permanent human bone marrow stromal cell lines with long-term post irradiation feeder capacity. Blood 83:1799-1807.
60. Tsui, L. V., M. Kelly, N. Zayek, V. Rojas, K. Ho, Y. Ge, M. Moskalenko, J. Mondesire, J. Davis, M. V. Roey, T. Dull, and J. G. McArthur. 2002. Production of human clotting Factor IX without toxicity in mice after vascular delivery of a lentiviral vector. Nat. Biotechnol. 20:53-57.
61. Vanden Driessche, T., L. Thorrez, L. Naldini, A. Follenzi, L. Moons, Z. Berneman, D. Collen, and M. K. Chuah. 2002. Lentiviral vectors containing the human immunodeficiency virus type-1 central polypurine tract can efficiently transduce nondividing hepatocytes and antigen-presenting cells in vivo. Blood 100:813-822.
62. Varmus, H. 1988. Retroviruses. Science 240:1427-1435.
63. Verma, I. M., and N. Somia. 1997. Gene therapy - promises, problems and prospects. Nature 389:239-242.
64. Vigna, E., and L. Naldini. 2000. Lentiviral vectors: excellent tools for experimental gene transfer and promising candidates for gene therapy. J. Gene Med. 2:308-316.
65. Vile, R. G., and S. J. Russell. 1995. Retroviruses as vectors. Br. Med. Bull. 51:12-30.
66. Wivel, N. A., G.-P. Gao, and J. M. Wilson. 1999. Adenovirus vectors, p. 87-110. In T. Friedmann (ed.), The development of gene therapy. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
67. Ye, X., V. M. Rivera, P. Zoltick, F. Cerasoli, Jr., M. A. Schnell, G. Gao, J. V. Hughes, M. Gilman, and J. M. Wilson. 1999. Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer. Science 283:88-91.
68. Yoshida, Y., N. Emi, and H. Hamada. 1997. VSV-G-pseudotyped retroviral packaging through adenovirus-mediated inducible gene expression. Biochem. Biophys. Res. Commun. 232:379-382.
69. Zufferey, R., J. E. Donello, D. Trono, and T. J. Hope. 1999. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J. Virol. 73:2886-2892.
70. Zufferey, R., D. Nagy, R. J. Mandel, L. Naldini, and D. Trono. 1997. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol. 15:871-875.